| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.09B | 3.97B | 3.48B | 2.97B | 2.33B |
| Gross Profit | 1.43B | 1.45B | 1.25B | 1.12B | 910.44M |
| EBITDA | 287.41M | 332.97M | 302.66M | 258.55M | 143.44M |
| Net Income | 74.75M | 144.15M | 145.45M | 187.86M | 60.80M |
Balance Sheet | |||||
| Total Assets | 3.27B | 2.98B | 2.54B | 2.00B | 1.57B |
| Cash, Cash Equivalents and Short-Term Investments | 806.37M | 810.82M | 1.20B | 803.47M | 680.20M |
| Total Debt | 475.90M | 469.96M | 160.30M | 261.91M | 577.77M |
| Total Liabilities | 1.23B | 944.09M | 705.00M | 660.50M | 907.28M |
| Stockholders Equity | 2.04B | 2.04B | 1.83B | 1.33B | 663.23M |
Cash Flow | |||||
| Free Cash Flow | -433.11M | -507.44M | 185.16M | 52.81M | 10.63M |
| Operating Cash Flow | 111.20M | 137.60M | 299.54M | 224.54M | 145.27M |
| Investing Cash Flow | -563.04M | -691.27M | -116.84M | -195.50M | -176.26M |
| Financing Cash Flow | 145.90M | 167.65M | 210.67M | 94.22M | 485.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.77B | 30.00 | ― | 1.87% | 1.62% | ― | |
67 Neutral | ¥2.27B | -15.53 | ― | ― | ― | ― | |
66 Neutral | ¥4.71B | 7.32 | ― | 2.70% | -3.33% | 30.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥4.28B | 9.29 | ― | 3.64% | -1.69% | -18.95% | |
45 Neutral | ¥3.36B | -8.36 | ― | ― | 150.27% | 233.12% | |
41 Neutral | ¥2.63B | -5.39 | ― | ― | -5.20% | 75.97% |